Chronic diarrhea is an important cause of morbidity and mortality in patien
ts infected with the human immunodeficiency virus (HIV). In most cases, a p
athogen can be identified by stool examination or by endoscopy when stool t
ests are negative. In this article, the authors review the etiology and dia
gnostic evaluation of chronic diarrhea in HIV associated diarrhea in the er
a of highly active antiretroviral therapy (HAART). In this patient populati
on, the introduction of HAART has been associated with a decrease in the in
cidence of opportunistic pathogens, better response rates to empiric and pa
thogen-specific therapy, and prolonged survival. Finally, the authors highl
ight some of the newer therapeutic agents for the treatment of chronic HIV-
associated diarrhea.